A decade of innovation, guidelines, and paradigm shifts in LDL-c management - PACE-CME

1-4 of 4

LDL-c: new insights into its role as causal risk factor and target for therapy
LDL-c: new insights into its role as causal risk factor and target for therapy
A decade of innovation, guidelines, and paradigm shifts in LDL-c management
LDL-c: new insights into its role as causal risk factor and target for therapy
Prof. Brian Ference, MD
- Prof. Brian Ference, MD
Addressing the unmet needs in LDL-c lowering; what can we expect?
Addressing the unmet needs in LDL-c lowering; what can we expect?
A decade of innovation, guidelines, and paradigm shifts in LDL-c management
Addressing the unmet needs in LDL-c lowering; what can we expect?
Prof. John Kastelein, MD
- Prof. John Kastelein, MD
Targeting the PCSK9 pathway: where do novel therapies fit in?
Targeting the PCSK9 pathway: where do novel therapies fit in?
A decade of innovation, guidelines, and paradigm shifts in LDL-c management
Targeting the PCSK9 pathway: where do novel therapies fit in?
Ann Marie Navar, MD, PhD
- Ann Marie Navar, MD, PhD
Changing paradigms in LDL-c reduction
Changing paradigms in LDL-c reduction
A decade of innovation, guidelines, and paradigm shifts in LDL-c management
Changing paradigms in LDL-c reduction
Prof Kausik Ray
- Prof Kausik Ray